Other related webinars
Essential Regulatory Perspectives and Best Clini...
Monday, 7th February, 2011
Time : 01:00 PM EST | 10:00 AM PST
Biggest challenge for Pharmaceuticals/ Biotechno...
Tuesday, 22nd February, 2011
Time : 10:00 AM | 07:00 AM
Critical aspects of applying QbD to pharmaceutic...
Friday, 6th May, 2011
Time : 02:00 PM | 11:00 AM
Biologics Battlefield: Opportunities and Obstacl...
Thursday, 30th June, 2011
Time : 02:00 PM | 11:00 AM
Vital Success/Failure Regulatory Perspectives an...
Thursday, 15th September, 2011
Time : 02:00 PM | 11:00 AM
Good Laboratory Practices (GLP) Compliance and A...
Friday, 11th November, 2011
Time : 02:00 PM | 11:00 AM
Good Clinical Practice (GCP): FDA Regulations, S...
Thursday, 26th January, 2012
Time : 02:00 PM EST | 11:00 AM PST
Orphan Drugs in Europe – How to use observatio...
Friday, 1st June, 2012
Time : 02:00 PM EST | 11:00 AM PST
Implementing the Compliant Good Laboratory Pract...
Friday, 10th August, 2012
Time : 02:00 PM EST | 11:00 AM PST
An overview of an innovative patient-centric ser...
Wednesday, 12th September, 2012
Time : 02:00 PM EST | 11:00 AM PST
An overview of Translational Medicine
Friday, 21st September, 2012
Time : 02:00 PM EST | 11:00 AM PST
Optimizing Site Selection for Global Clinical Tr...
Friday, 26th October, 2012
Time : 02:00 PM EST | 11:00 AM PST
Optimal clinical supply planning for global drug...
Friday, 16th November, 2012
Time : 02:00 PM EST | 11:00 AM PST
Patient Recruitment & Retention Management in Cl...
Monday, 10th December, 2012
Time : 02:00 PM EST | 11:00 AM PST
GMP's for Dietary Supplements: Keys to Success w...
Thursday, 30th October, 2014
Time : 01:00 PM EST | 10:00 AM PST
Is It Safe? A Cautionary Tale and Practical Guid...
Friday, 9th January, 2015
Time : 02:00 PM EST | 11:00 AM PST
How To Reconcile ICH GCP With RISK BASED Monitor...
Thursday, 19th March, 2015
Time : 11:00 AM IST | 06:30 PM BET
Orphan Drugs : Regulation and Reimbursement Cond...
Friday, 22nd July, 2016
Time : 01:00 PM EST | 10:00 AM PST
Panel Discussion on Best Practices to Clinical T...
Friday, 10th March, 2017
Time : 04:00 PM IST | 11:30 AM BST
FDA Requirements for Good Clinical Practice’s ...
Friday, 7th July, 2017
Time : 04:00 PM IST | 11:30 AM BST
Implementation of Pharmaceutical Quality system ...
Friday, 17th November, 2017
Time : 01:00 PM EST | 10:30 AM PST
FDA Guidance for ICH GCP E6 R2 Means for Sponsor...
Thursday, 27th September, 2018
Time : 04:00 PM IST | 03:30 AM PDT
Managing Human Error in Quality Systems: Human E...
Friday, 17th July, 2020
Time : 01:00 PM EST | 10:00AM PST
FDA approvals of Orphan Drugs and Rare Diseases:...
Friday, 24th July, 2020
Time : 01:00 PM EST | 10:30 AM PST
FDA approvals of Orphan Drugs and Rare Diseases:...
Friday, 26th August, 2022
Time : 01:00 PM EST | 10:00 AM PST
Good Documentation Guideline (Chapter <1029> USP...
Friday, 11th November, 2022
Time : 01:00 PM EDT | 10:00 AM PST
FDA - Investigating OOS results
Friday, 17th March, 2023
Time : 01:00 PM EDT | 10:00 AM PDT
Best Practices for FDA's Investigating Deviation...
Friday, 26th May, 2023
Time : 01:00 PM EDT | 10:00 AM PDT
Recorded Webinar
Is It Safe? A Cautionary Tale and Practical Guide to Laboratory Safety and Compliance with the OSHA Lab Standard Regulations
timelapse 60 mins with 10-15 mins of Q and A
Note:
This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times
Speaker/Presenter
Short Abstract
Despite continuing improvements in safety standards and practices over the years in academic and industrial research laboratories, accidents, injuries and even death still occur with alarming frequency. This presentation will discuss several prominent accidents that have made headlines in recent years, discuss lessons learned and review key elements of the OSHA Lab Standards that regulate many of the hazardous operations and conditions commonly encountered in the modern chemical research laboratory.
Areas Covered in the Webinar:
- Review of several recent high profile lab accidents having the common theme of mishandled chemicals, poor training and/or violation of generally accepted standards and practices
- Review key lessons to be learned from these events to help avoid such tragic mishaps in future
- A brief history of OSHA and EPA legislation and its overall impact on workplace health and safety metrics
- Review major elements of the OSHA Lab Standards (29 CFR 1910.1450) requiring compliance as part of a comprehensive safety program within research labs in industry and academia
- Guide to key references and resources relating to lab safety and chemical hygiene
- Recap including a discussion of the proven value and ethics of integrating and nurturing a strong laboratory safety program within the overall corporate culture of research organizations
Who should attend
Anyone who is involved in Laboratory Safety and Compliance/Regulations etc.
Content Disclaimer
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.